Analyst Ratings for Genmab A/S (GMAB)
GMAB Rating Summary
GMAB Price Target Summary
- Highest: $58.00 (Guggenheim)
- Lowest: $30.50 (Goldman Sachs)
- Average: $42.30
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$42.30 (+14.3%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 78%
Rating Score: 7.5 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/5/2026 | Leerink | Asthika Goonewardene | New Coverage | Outperform (N/A) |
50.00 (N/A) |
34.75 (37.00) |
6.47% | Details |
| 7/22/2026 | TD Cowen | Yaron Werber | Upgrade | Buy (Hold) |
43.00 (32.00) |
28.37 (37.00) |
30.42% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
